1. bookVolume 22 (2015): Issue 1 (March 2015)
Journal Details
License
Format
Journal
First Published
01 May 2012
Publication timeframe
4 times per year
Languages
English
access type Open Access

Abdominal Obesity – A Cardiometabolic Risk Factor

Published Online: 25 Mar 2015
Page range: 67 - 72
Received: 02 Dec 2014
Accepted: 08 Feb 2015
Journal Details
License
Format
Journal
First Published
01 May 2012
Publication timeframe
4 times per year
Languages
English

Background and aims: In the modern society, obesity represents an important health issue, both because the great number of obese patients in the developed and developing countries and the complications that occur in obese patients, accompanied by an increased risk for cardio-metabolic complications, cancer and death. Material and methods: Among the numerous data recorded in the literature, I made reference to about 30 articles supporting certain hypotheses or truths regarding the pathogenesis of obesity and its cardio-metabolic consequences.

Keywords

1. Phillips CM, Tierney AC, Perez-Martinez P et al. Obesity and body fat classification in the metabolic syndrome: Impact on cardiometabolic risk metabotype. Obesity (Silver Spring) 21: E154-E161, 2013.Search in Google Scholar

2. Bala C. Complicațiile obezității. În Șerban V. Tratat român de boli metabolice, vol. 2, p.379-86, Editura BrumaR, Timișoara, 2011Search in Google Scholar

3. Arnold AC, Diz DI. Endogenous leptin contributes to baroreflex suppression within the solitary tract nucleus of aged rats. Am J Physiol Heart Circ Physiol 307: H1539-H1546, 2014.Search in Google Scholar

4. Baggio LL, Drucker DJ. Glucagon-like peptide-1 receptors in the brain: controlling food intake and body weight. J Clin Invest 124: 4223-4226, 2014.Search in Google Scholar

5. Coculescu M, Mocanu V, Gheorghiu ML. Etiopatogenia obezității. În Șerban V. Tratat român de boli metabolice, vol. 2, p.339-363, Editura BrumaR, Timișoara, 2011.Search in Google Scholar

6. Shohamy D, Wimmer GE. Dopamine and the cost of aging. Nat Neurosci. 16: 519-521, 2013.Search in Google Scholar

7. Ge Q, Maury E, Rycken L et al. Endocannabinoids regulate adipokine production and the immune balance of omental adipose tissue in human obesity. Int J Obes (Lond) 37: 874-880, 2013.Search in Google Scholar

8. Labouèbe G, Liu S, Dias C et al. Insulin induces long-term depression of ventral tegmental area dopamine neurons via Endocannabinoids. Nat Neurosci.16: 300-308, 2013.Search in Google Scholar

9. Laque A, Zhang Y, Gettys S et al. Leptin receptor neurons in the mouse hypothalamus are colocalized with the neuropeptide galanin and mediate anorexigenic leptin action. Am J Physiol Endocrinol Metab 304: E999-E1011, 2013.Search in Google Scholar

10. Lee SJ, Verma S, Simonds SE et al. Leptin stimulates neuropeptide Y and cocaine amphetamineregulated transcript co-expressing neuronal activity in the dorsomedial hypothalamus in diet-induced obese mice. J Neurosci 33: 15306-15317, 2013.Search in Google Scholar

11. Pandit R, Luijendijk MM, Vanderschuren LJMJ, la Fleur SE, Adan RAH. Limbic substrates of the effects of neuropeptide Y on intake of and motivation for palatable food. Obesity (Silver Spring) 22: 1216-1219, 2014.Search in Google Scholar

12. Hilzendeger AM, Morgan DA, Brooks L et al. A brain leptin-renin angiotensin system interaction in the regulation of sympathetic nerve activity. Am J Physiol Heart Circ Physiol 303: H197-H206, 2012.Search in Google Scholar

13. Patarrão RS, Lautt WW, Macedo PM. Assessment of methods and indexes of insulin sensitivity. Rev Port Endocrinol Diabetes Metab 09: 65-73, 2014.Search in Google Scholar

14. de Luis D, Gonzales Sagrado M, Aller R, Izaola O, Conde R. Influence of G1359A polymorphism of the cannabinoid receptor gene on anthropometric parameters and insulin resistance in women with obesity. Metabolism 60: 272-276, 2011.Search in Google Scholar

15. Sundell J, Raitakari OT, Viikari J, Kantola I, Nuutila P, Knuuti J. Both BMI and waist circumference are associated with coronary vasoreactivity in overweight and obese men. Obes Facts 5: 693-699, 2012.Search in Google Scholar

16. Meyer LK, Ciaraldi TP, Henry RR, Wittgrove AC, Phillips SA.. Adipose tissue depot and cell size dependency of adiponectin synthesis and secretion in human obesity. Adipocyte 2: 217-226, 2013.Search in Google Scholar

17. Sultan A, Fabre O, Fédou, C et al. P2110 L’insulinorésistance musculaire précède l’apparition d’une insulinorésistance dans le tissu adipeux: étude chez la femme obèse menopause. Diabet Metab 39: A94, 2013 (Abstract)Search in Google Scholar

18. Bala C. Etiopatogeneza, fiziopatologia, morfopatologia obezității. În Hâncu N, Roman G, Vereșiu IA. Diabetul zaharat, nutriția și bolile metabolice, Tratat 2, p. 25-76, Editura Echinox, Cluj Napoca, 2010.Search in Google Scholar

19. Hazlehurst JM, Gathercole LL, Nasiri M et al. Glucocorticoids fail to cause insulin resistance in human subcutaneous adipose tissue in vivo. J Clin Endocrinol Metab 98: 1631-1640, 2013.Search in Google Scholar

20. Guillemette L, Lacroix M, Battista MC et al. TNFα dynamics during the oral glucose tolerance test vary according to the level of insulin resistance in pregnant women. J Clin Endocrinol Metab 99: 1862-1869, 2014.Search in Google Scholar

21. Jialal I, Devaraj S, Kaur H, Adams-Huet B, Bremer AA. Increased chemerin and decreased omentin-1 in both adipose tissue and plasma in nascent metabolic syndrome. J Clin Endocrinol Metab 98: E514-E517, 2013.Search in Google Scholar

22. Lin SX, Berlin I, Younge R et al. Does elevated plasma triglyceride level independently predict impaired fasting glucose? The multi-ethnic study of atherosclerosis (MESA). Diabetes Care 36: 342-347, 2013.Search in Google Scholar

23. Robinson JG, Ballantyne CM, Hsueh WA et al. Age, abdominal obesity, and baseline high-sensitivity Creactive protein are associated with low-density lipoprotein cholesterol, non-high-density lipoprotein cholesterol, and apolipoprotein B responses to ezetimibe/simvastatin and atorvastatin in patients with metabolic syndrome. J Clin Lipidol 7: 292-303, 2013.Search in Google Scholar

24. Taverne F, Richard C, Couture P, Lamarche B. Abdominal obesity, insulin resistance, metabolic syndrome and cholesterol homeostasis. PharmaNutrition 1: 130-136, 2013.Search in Google Scholar

25. Salazar MR, Carbajal HA, Espeche WE et al. Relation among the plasma triglyceride/high-density lipoprotein cholesterol concentration ratio, insulin resistance, and associated cardio-metabolic risk factors in men and women. Am J Cardiol 109: 1749-1753, 2012.Search in Google Scholar

26. Maher CA, Mire E, Harrington DM, Staiano AE, Katzmarzyk PT. The independent and combined associations of physical activity and sedentary behavior with obesity in adults: NHANES 2003-06. Obesity 21: E730-E737, 2013.Search in Google Scholar

27. Karpe F, Dickman JR, Frayn KN. Fatty acids, obesity, and insulin resistance: time for a reevaluation. Diabetes 60: 2441-2449, 2011. Search in Google Scholar

28. Bala C., Niță C. Etiopatogeneza sindromului metabolic. În Hâncu N, Roman G, Vereșiu IA. Diabetul zaharat, nutriția și bolile metabolice, Tratat 2, p. 475-94, Editura Echinox, Cluj Napoca, 2010.Search in Google Scholar

29. Bojic LA, Burke AC, Chhoker SS et al. Peroxisome proliferator-activated receptor δ agonist GW1516 attenuates diet-induced aortic inflammation, insulin resistance, and atherosclerosis in low-density lipoprotein receptor knockout mice. Arterioscler Thromb Vasc Biol 34: 52-60, 2014.Search in Google Scholar

30. Mauer J, Chaurasia B, Goldau J et al. Signaling by IL-6 promotes alternative activation of macrophages to limit endotoxemia and obesity-associated resistance to insulin. Nat Immunol 15: 423-430, 2014.Search in Google Scholar

31. Scheele C, Nielsen S, Kelly M et al. Satellite cells derived from obese humans with type 2 diabetes and differentiated into myocytes in vitro exhibit abnormal response to IL-6. PLoS ONE 7: e39657, 2012.Search in Google Scholar

32. da Cunha NV, Pinge-Filho P, Panis C et al. Decreased endothelial nitric oxide, systemic oxidative stress, and increased sympathetic modulation contribute to hypertension in obese rats. Am J Physiol Heart Circ Physiol 306: H1472-H1480, 2014.Search in Google Scholar

33. Toda N, Okamura T. Obesity impairs vasodilatation and blood flow increase mediated by endothelial nitric oxide: An overview. J Clin Pharmacol 53: 1228-1239, 2013. Search in Google Scholar

Recommended articles from Trend MD

Plan your remote conference with Sciendo